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Cancer in all forms are resulting in about 12% of death 
throughout the world.1 In developed countries cancer is 
the second leading cause of death accounting for 21% (2.5 
million) of all mortality.2 In developing countries cancer 
ranks third as a cause of death and accounts for 9.5% (3.8 
million) of all deaths.3 
 
WHO has estimated that 91% of oral cancers in South-
East Asia are directly attributable to the use of tobacco 
and total cancer burden in India for all sites will increase 
from 7 lakhs new cases per year to 14 lakhs per year by 
2026.4 Worldwide, cancer of the mouth results in the 
death of 2 million people every year. In USA , it is the 
leading killer disease next to the cardio vascular disease. 
As in a survey by ICMR it has been stated that amongst all 
Cancer of our body constitutes 30% of the oral cancer 
which is a matter of big concern. Cancer does not spare 
rich or poor.5 Underprivileged people are either unaware 
or are not able to afford the required treatment. Oral 
Cancer occurs mainly among poor people who have high 
intake of gutkha, khaini etc. Other Cancers of our body 
e.g. cancer of ovary, uterus, breast, colon, etc are more 
common among the rich people; but this section of 
society can afford the treatment.6 
 
DISCUSSION 
Very frequently we the “dental surgeon” have to examine 
the patients suffering from oral cancers. 
 
Pre-malignant lesions if treated properly, may not turn 
into malignancy and hence, patients with squamous cell 
carcinoma constitutes around  90% of oral cancers and is 
a malignant one.7 
 
Stage I & Stage II of squamous cell carcinoma are 
amenable to surgery, whereas Stage III & IV involves 
bone, vascular structures and multiple lymph nodes are 
treated with combination therapy consisting of surgery 
and irradiation surgery and chemotherapy.8  
 
Irradiation is done by three methods: interstitial, 
implantation as done in brachytherapy and external beam 
methods. Radiation therapy is usually given within 6 
weeks of surgical dissection.9 The tumoricidal dose of 
external beam irradiation ranges from 5000 CGy 
(Centigray) to 7000 CGy given in separate dose of 150-200 
CGy over 6 to 8 weeks period.10 
 
Higher Survival rates are associated with early diagnosis, 
younger age, early cancer Stage I & Stage II involving 
anterior sites with cancer depth of 5 mm or less and 
carcinomas that do not metastasize in bone. Recurrence 
are more common in patients who do not stop alcohol 
and tobacco products.11 
 
DENTAL MANAGEMENT IN PREVIEW OF 
RECOGNIZATION OF CANCER AND MEDICAL 
CONSIDERATIONS 
When a patient visits the dentist, he should have a 
consistent approach for ascertaining related medical, 
historical and clinical information from the patient. A 
dentist should ask the patient the following: “Have you 
experienced any change in your health since the last 
visit?”, “Are you aware of any lump on bump developing 
under your  arm  or  in   your  neck for any apparent 
reasons”, “do your suffer from any abnormal bleeding 
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from any ulcer in your tongue or mucosa which is did not 
heal within 3 weeks?”.12 The patient should be examined 
thoroughly for any hard, fixed or matted lymph nodes. A 
pre-treatment oral evaluation is mandatory for all cancer 
patients before initiation of cancer therapy for:  
 
1. Ruling out any oral disease that may aggravate during 
cancer therapy. 
2. Providing a baseline for comparison and monitoring 
squeal of Irradiation and chemotherapy damage. 
3. Minimizing oral discomfort during cancer therapy. 
 
IRRADIATION 
Most of the dental surgeons are aware of the complication 
of irradiation and chemotherapy. In irradiation therapy 
the healthcare professionals are mainly are concerned 
about: 
 
1. Osteoradionecrosis: This complication is greatest in 
posterior mandibular sites & subjects who have received 
radiation dosage in excess of 6500 CGy. This is the new SI 
unit earlier it was RAD (Radiation Absorbed Dose). Now 
100 RAD = 1 CGy.13 
2. The dental surgeon should be aware of another 
important factor which is basically development of 
“carotid stenosis” which is likely to develop in carotid 
artery if irradiation is given at a dose 45 Gy or more in 
neck region. This may add up as a risk factor of stroke. 
3. Risk is greater for patients who are dentulous rather 
than edentulous. 
4. To reduce the possibility of developing 
osteoradionecrosis, the dental surgeon should think of 
selecting edentulous over extraction and use of local 
anesthesia without adrenaline.  
5.  Atraumatic surgical procedure as much as possible 
should be employed. 
6. Prophylactic antibiotics plus antimicrobials should be 
given during the healing process and dosage should be 
higher than the normal schedule. 
7. Hyperbaric oxygen therapy using sequential daily dives 
under 2 atmospheric pressure in a chamber should be 
given. 
8. Once necrosis has occurred conservative management 
is usually indicated and exposed bone should be irrigated 
with saline and antibiotic solution. 
 
Amongst the other complications are :- 
i. Xerostomia 
ii. Mucositis 
iii. Submandibular lymphadenopathy 
iv. Radiation caries 
v. Burning mouth syndrome 
vi. Dysgeusia or Ageusia 
 
CHEMOTHERAPY 
If the cancer patient receiving chemotherapy has to 
undergo any oral procedure, dental surgeon should adjust 
the patient's dosage based on routine hemogram and 
clotting factors.14 Routine oral procedure can’t be done if 
the granulocyte count particularly Neutrophil count is 
below 1500/mm3 and platelet count less than 50,000/µm. 
These patients might develop thrombocytopenia and 
neutropenia due to high dose of chemotherapy resulting 
in bone marrow depression. If it is a chemotherapeutic 
induced myelosuppression, it will recover in 6 weeks 
spontaneously.15 One of the most important concern is 
indwelling Hickman Catheter or port that are susceptible 
to infection which can be prevented by prophylactic 
antibiotics given during oral procedures. 
 
For a patient who is undergoing radiotherapy or 
chemotherapy the following notes should be kept in mind 
by the dental surgeons prior to any dental procedure.16 
 
1. Acute toxicity occurs immediately during and after 
radiotherapy & chemotherapy. The severity of such 
toxicity is directly proportional to cytotoxic drugs. 
Chemotherapy is most effective at killing cells that are 
rapidly dividing. 
2. Delayed toxicity occurs in several months to years 
after radiation therapy. Amongst all the toxicities, a 
dental surgeon encounters patients with mucositis, 
xerostomia, radiation caries, secondary infection, 
sensitivity of teeth, complete agesia, muscular 
dysfunction and osteoradionecrosis. Osteoradionecrosis 
is a condition characterized by exposed base bone that 
fails to heal even months after radiation. This condition is 
most common in posterior mandibular sites where 
vascularity is very less. 
 
Bisphosphonates: These have two phosphonate groups 
hence are called diphosphonates. It is a class of drugs that 
prevent loss of bone density and is used to treat 
osteoporosis and similar disease. They reduce the risk of 
fracture in post-menopausal women with osteoporosis.17 
Bone tissue undergoes constant remodelling by bone 
creating osteoblasts and bone destroying osteoclasts. 
Bisphosphonates inhibits the digestion of bone by 
encouraging osteoclasts to undergo-apoptosis.  
   
CONCLUSION 
Cancer is emerging as important non-communicable 
public health problem of the world. The epidemiology of 
cancer, its control and prevention measures are 
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applicable to the world including the Indian sub-
continent. The major risk factors for the disease are 
tobacco, dietary habits, inadequate physical activity, 
alcohol consumption and infections due to viruses. The 
greatest impact to reduce the burden of cancer comes 
from primary prevention, extensive persuasive health 
education being the basic one. 
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